These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 35246608)
1. Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men. Henning GM; Andriole GL; Kim EH Prostate Cancer Prostatic Dis; 2022 Feb; 25(2):180-186. PubMed ID: 35246608 [TBL] [Abstract][Full Text] [Related]
2. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Tomlins SA; Day JR; Lonigro RJ; Hovelson DH; Siddiqui J; Kunju LP; Dunn RL; Meyer S; Hodge P; Groskopf J; Wei JT; Chinnaiyan AM Eur Urol; 2016 Jul; 70(1):45-53. PubMed ID: 25985884 [TBL] [Abstract][Full Text] [Related]
3. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions. Hendriks RJ; van Oort IM; Schalken JA Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):12-19. PubMed ID: 27922627 [TBL] [Abstract][Full Text] [Related]
4. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Hughes L; Zhu F; Ross E; Gross L; Uzzo RG; Chen DY; Viterbo R; Rebbeck TR; Giri VN Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):53-60. PubMed ID: 22144497 [TBL] [Abstract][Full Text] [Related]
5. Contemporary role of prostate cancer antigen 3 in the management of prostate cancer. Auprich M; Bjartell A; Chun FK; de la Taille A; Freedland SJ; Haese A; Schalken J; Stenzl A; Tombal B; van der Poel H Eur Urol; 2011 Nov; 60(5):1045-54. PubMed ID: 21871709 [TBL] [Abstract][Full Text] [Related]
6. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the ERSPC risk calculator for prostate cancer in prescreened men. Vedder MM; de Bekker-Grob EW; Lilja HG; Vickers AJ; van Leenders GJ; Steyerberg EW; Roobol MJ Eur Urol; 2014 Dec; 66(6):1109-15. PubMed ID: 25168616 [TBL] [Abstract][Full Text] [Related]
7. A critical appraisal of biomarkers in prostate cancer. Narayan VM World J Urol; 2020 Mar; 38(3):547-554. PubMed ID: 30993424 [TBL] [Abstract][Full Text] [Related]
8. Clinical Use of PCA3 and TMPRSS2:ERG Urinary Biomarkers in African-American Men Undergoing Prostate Biopsy. Feibus AH; Sartor O; Moparty K; Chagin K; Kattan MW; Ledet E; Levy J; Lee B; Thomas R; Silberstein JL J Urol; 2016 Oct; 196(4):1053-60. PubMed ID: 27140073 [TBL] [Abstract][Full Text] [Related]
9. A Multi-Institutional Prospective Trial Confirms Noninvasive Blood Test Maintains Predictive Value in African American Men. Punnen S; Freedland SJ; Polascik TJ; Loeb S; Risk MC; Savage S; Mathur SC; Uchio E; Dong Y; Silberstein JL J Urol; 2018 Jun; 199(6):1459-1463. PubMed ID: 29223389 [TBL] [Abstract][Full Text] [Related]
10. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Giri VN; Egleston B; Ruth K; Uzzo RG; Chen DY; Buyyounouski M; Raysor S; Hooker S; Torres JB; Ramike T; Mastalski K; Kim TY; Kittles R Cancer Prev Res (Phila); 2009 Mar; 2(3):244-50. PubMed ID: 19240249 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers of Aggressive Prostate Cancer at Diagnosis. Boehm BE; York ME; Petrovics G; Kohaar I; Chesnut GT Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768533 [TBL] [Abstract][Full Text] [Related]
12. Comparative assessment of urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion with the serum [-2]proprostate-specific antigen-based prostate health index for detection of prostate cancer. Stephan C; Jung K; Semjonow A; Schulze-Forster K; Cammann H; Hu X; Meyer HA; Bögemann M; Miller K; Friedersdorff F Clin Chem; 2013 Jan; 59(1):280-8. PubMed ID: 23213079 [TBL] [Abstract][Full Text] [Related]
13. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371 [TBL] [Abstract][Full Text] [Related]
14. Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml. Ferro M; Bruzzese D; Perdonà S; Marino A; Mazzarella C; Perruolo G; D'Esposito V; Cosimato V; Buonerba C; Di Lorenzo G; Musi G; De Cobelli O; Chun FK; Terracciano D PLoS One; 2013; 8(7):e67687. PubMed ID: 23861782 [TBL] [Abstract][Full Text] [Related]
15. Optimizing prostate cancer screening; prospective randomized controlled study of the role of PSA and PCA3 testing in a sequential manner in an opportunistic screening program. Rubio-Briones J; Casanova J; Dumont R; Rubio L; Fernandez-Serra A; Casanova-Salas I; Domínguez-Escrig J; Ramírez-Backhaus M; Collado A; Gómez-Ferrer A; Iborra I; Monrós JL; Ricós JV; Solsona E; Salas D; Martínez F; Lopez-Guerrero JA Actas Urol Esp; 2014 May; 38(4):217-23. PubMed ID: 24169211 [TBL] [Abstract][Full Text] [Related]
16. A Prospective Adaptive Utility Trial to Validate Performance of a Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer in Patients with Prostate-specific Antigen 2-10ng/ml at Initial Biopsy. McKiernan J; Donovan MJ; Margolis E; Partin A; Carter B; Brown G; Torkler P; Noerholm M; Skog J; Shore N; Andriole G; Thompson I; Carroll P Eur Urol; 2018 Dec; 74(6):731-738. PubMed ID: 30237023 [TBL] [Abstract][Full Text] [Related]
17. Genomic Markers in Prostate Cancer Decision Making. Cucchiara V; Cooperberg MR; Dall'Era M; Lin DW; Montorsi F; Schalken JA; Evans CP Eur Urol; 2018 Apr; 73(4):572-582. PubMed ID: 29129398 [TBL] [Abstract][Full Text] [Related]
18. Assessment of high-grade prostate cancer risk using prostate cancer biomarkers. Stanton WN; Crawford ED; Arangua PB; La Rosa FG; van Bokhoven A; Lucia MS; Poage WL; Partin A; Maroni P; Werahera PN Can J Urol; 2020 Feb; 27(1):10080-10085. PubMed ID: 32065862 [TBL] [Abstract][Full Text] [Related]
19. Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal Biomarkers. Filella X; Foj L Int J Mol Sci; 2016 Oct; 17(11):. PubMed ID: 27792187 [TBL] [Abstract][Full Text] [Related]
20. Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy. Ochiai A; Okihara K; Kamoi K; Oikawa T; Shimazui T; Murayama S; Tomita K; Umekawa T; Uemura H; Miki T BJU Int; 2013 May; 111(6):928-33. PubMed ID: 23331404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]